Uni-Bio Science Group

Uni-Bio Science Group Current Assets

The Current Assets of Uni-Bio Science Group (690.HK) as of Oct 17, 2026 is 318.78 M HKD. In the previous year, Current Assets was 238.10 M HKD — a change of 33.89% (higher).

Current Assets

318.78 MHKD

YoY

33.89%

Last updated:

Current Assets of Uni-Bio Science Group is 2024 318.78 M HKD. Current Assets of Uni-Bio Science Group was 2023 238.10 M HKD. It decreases by 33.89% higher compared to the previous year.

The Uni-Bio Science Group Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
205.82 M HKD
Jan 1, 2018
104.06 M HKD
Jan 1, 2019
192.47 M HKD
Jan 1, 2020
181.44 M HKD
Jan 1, 2021
201.67 M HKD
Jan 1, 2022
200.34 M HKD
Jan 1, 2023
238.10 M HKD
Jan 1, 2024
318.78 M HKD
The Uni-Bio Science Group Current Assets history
YEARCurrent AssetsYoY
318.78 MHKD+33.89%
238.10 MHKD+18.85%
200.34 MHKD-0.66%
201.67 MHKD+11.15%
181.44 MHKD-5.73%
192.47 MHKD+84.95%
104.06 MHKD-49.44%
205.82 MHKD+55.69%
132.20 MHKD-18.27%
161.75 MHKD-12.26%
184.35 MHKD-27.53%
254.40 MHKD+272.47%
68.30 MHKD-47.14%
129.20 MHKD+23.52%
104.60 MHKD-32.39%
154.70 MHKD-47.13%
292.60 MHKD-45.45%
536.40 MHKD+93.93%
276.60 MHKD+270.28%
74.70 MHKD-21.86%
95.60 MHKD-6.91%
102.70 MHKD+6.98%
96.00 MHKD-7.96%
104.30 MHKD+89.98%
54.90 MHKD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Uni-Bio Science Group Stock analysis

What does Uni-Bio Science Group do? Uni-Bio Science Group Ltd, listed on the Hong Kong Stock Exchange under ticker 690.HK with ISIN KYG9198H1406, operates in the Health Care sector within the Biotechnology industry. The company, which completed its IPO on November 12, 2001, employs 340 full-time staff. Uni-Bio Science Group functions through four business segments. The In-house Chemical Pharmaceutical Products segment focuses on manufacturing and selling proprietary chemical pharmaceutical products, including the product named Pinapu. The In-house Biological Pharmaceutical Products segment handles the production and distribution of biological pharmaceutical products such as GeneTime and GeneSoft. The In-house Biological Pipeline segment is dedicated to advancing the industrialization of its biological pipeline, featuring products like Uni-E4 and Uni-PTH. The Third-party Pharmaceutical Products segment manages the sales of pharmaceutical products from external suppliers. The company's headquarters location is not publicly specified, and its official website is www.uni-bioscience.com. Uni-Bio Science Group's business model integrates in-house development with third-party product distribution, targeting both chemical and biological pharmaceutical markets. The company's operational structure reflects a diversified approach to pharmaceutical research, development, and commercialization, though specific details about its research pipeline, market reach, or financial performance are not provided in the available information. Uni-Bio Science Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uni-Bio Science Group stock

Current Assets of Uni-Bio Science Group is 318.78 M HKD in 2024.

Current Assets of Uni-Bio Science Group changed from 238.10 M HKD to 318.78 M HKD, representing a 33.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Uni-Bio Science Group since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's HKD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Uni-Bio Science Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Uni-Bio Science Group

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Uni-Bio Science Group